ANNETTE DAVIS: Open Payments
NPI 1285720045 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 36 payments from 19 companies in 2025. Trend: 2023 $555 · 2024 $706 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 6 | $153 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $81 |
| ABBVIE INC. | 2 | $59 |
| Astellas Pharma US Inc | 3 | $56 |
| MILLICENT US INC | 3 | $44 |
| Novo Nordisk Inc | 2 | $32 |
| Boston Scientific Corporation | 1 | $28 |
| Exeltis, USA Inc. | 2 | $27 |
| JAZZ PHARMACEUTICALS INC. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $19 |
Products named: ZURZUVAE, Veozah, Wegovy, VRAYLAR, INTRAROSA, BodyGuardian, BOTOX, SLYND.
Industry payments across KY — which companies pay providers there.
